Ford worked as director of biostatistics for Corcept Therapeutics, a California pharmaceutical start-up, from 2006 to 2012, according to an
archive of her since-deleted LinkedIn page. Corcept
published six papers under her name.
But claiming that Corcept sells an abortion pill is like saying a road salt company sells food seasoning.
The company sells Korlym to treat Cushing's syndrome, a rare, deadly condition characterized by high cortisol levels. Korlym’s main ingredient, mifepristone, blocks the effect of cortisol.
That ingredient has another use.
Just like it blocks cortisol, mifepristone blocks progesterone, which is crucial to the development of a pregnancy. In a medication-induced abortion, mifepristone is administered first and another drug, misoprostol, follows. That empties the uterus by causing cramping and bleeding.
The latter drug, misoprostol, can and is used alone for abortions. However, the combination of both drugs is typically used for greater effectiveness and fewer side effects.
Mifepristone, on the other hand, is not administered alone to induce abortions. In some other countries, it is used alone as emergency contraception, according to Clare Flannery, a professor of endocrinology and reproductive sciences at Yale University. That’s not an abortifacient, according to Flannery, because it plays a role before the sperm and egg implant in the uterus. (Pregnancy occurs after implantation.)
In order to induce an abortion in the United States, a low dose of mifepristone is used only once in combination with misoprostol. Korlym patients take up to four times that dose of mifepristone daily for months or even years.